Researchers evaluated the burden of hepatitis C virus infection among adult patients with HIV infection in the United States during the era of direct-acting antiviral therapy.

Background: In the treatment of hepatitis C virus (HCV) infection, regimens including pegylated interferon-α are superior to those including standard interferon; the present retrospective study ...

RVR Undetectable HCV-RNA at week 4 of treatment by a sensitive, qualitative or quantitative HCV-RNA assay EVR ≥2 log reduction of HCV-RNA at week 12 of treatment compared to baseline level by a ...

Hepatitis C virus (HCV) is the major cause of liver disease worldwide and a potential source of high morbidity and mortality in the future. The World Health Organization estimates that ...

The researchers analyzed HCV trends across 3 separate calendar periods, including the interferon era (1995-2005), the early direct-acting antiviral (DAA) era (2006-2014), and the highly active DAA ...

if previously treated with regimens containing PEG-IFN, ribavirin, and/or sofosbuvir, but no prior treatment with an HCV NS3/4A protease inhibitor or NS5A inhibitor; (genotype 3): treat for 16 ...

RAR is a synthetic-modified RNA motif derived from the hepatitis C virus genome that is specifically recognized by RIG-I and ...

Get treatment for chronic hepatitis B infection: The treatment for chronic HBV infection can include interferon and nucleos .

Figure 1: Worldwide prevalence of hepatitis C in millions. HCV patients currently receive a combination of pegylated interferon-alfa (PEG–IFN) — either 2a (Roche's Pegasys) or 2b (Schering-Plo ...